SKBI Financial Facts
Total operating expenses: 3.36MPROVISION FOR INCOME TAXES: 712.93K
See Full Income Statement
Total assets: 171.61M
Short-term loans: 19.18M
See Full Balance Sheet
Skystar Bio Pharmaceutical Company (SKBI) Earnings
|
Expand Research on SKBI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/14/14 | Q214 | $0.37 | N/A | N/A | $14.2M | $11.3M | N/A |  | | Details | |
| 5/15/14 | Q413 | $0.13 | N/A | N/A | $6.83M | $5.53M | N/A | | | Details | |
| 11/15/13 | Q313 | $0.49 | N/A | N/A | $15.99M | $8.93M | N/A | | | Details | |
| 8/14/13 | Q213 | $0.49 | N/A | N/A | $11.3M | $8.9M | N/A | | | Details | |
| 5/16/13 | Q113 | $0.09 | N/A | N/A | $5.53M | $7.93M | N/A | | | Details | |
| 11/15/12 | Q312 | $0.36 | N/A | N/A | $8.9M | $20.9M | = | | | Details | |
| 8/14/12 | Q212 | $0.23 | N/A | N/A | $8.87M | $9.1M | = | | | Details | |
| 8/22/11 | Q211 | $0.21 | N/A | N/A | $9.1M | $8.26M | = | | | Details |
